U.S. government got $400 million in vaccine royalties from Moderna, company says
(Worthy News) – Pharmaceutical company Moderna indicated this week that it had sent the U.S. government a “catch-up” payment of $400 million in connection with a patent dispute.
The company concluded an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) in December of last year, establishing “a nonexclusive patent license agreement” allowing the company to use disputed technologies in its production of the COVID-19 vaccine, the Epoch Times reported.
In addition to the $400 million payment to NIAID, Moderna will “pay low single-digit royalties on future net sales of our COVID-19 vaccines,” according to Moderna CFO Jamey Mock. [ Source: Just the News (Read More…) ]
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.